Edinburgh Royal Infirmary

Running trials

• Not yet recruiting

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS)

  NCT07364045· University of Edinburgh· Source

• Recruiting

  Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study

  NCT07636642· University of Edinburgh· Source

• Recruiting

  Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

  NCT07346144· Phase 1/2· Trogenix ltd· Source

• Recruiting

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06968845· Phase 2· Rein Therapeutics· Source

• Recruiting

  Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

  NCT07284459· Phase 2· Contineum Therapeutics· Source

• Recruiting

  Early Detection and IntervenTion in Heart Failure

  NCT07731490· University Hospital, Basel, Switzerland· Source

• Recruiting

  Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging

  NCT07472049· University of Edinburgh· Source

• Recruiting

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation

  NCT06951100· University of Edinburgh· Source

• Recruiting

  Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery

  NCT06800430· University of Edinburgh· Source

• Recruiting

  Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

  NCT06435156· Phase 2· University of Dundee· Source

• Recruiting

  Non-invasive Coronary Thrombus Imaging to Define These Cause of Acute Myocardial Infarction

  NCT06113510· University of Edinburgh· Source

• Active, not recruiting

  RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

  NCT06823713· Phase 1/2· Resolution Therapeutics Limited· Source

• Active, not recruiting

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

  NCT06559150· Phase 2· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Source

• Active, not recruiting

  Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

  NCT06297603· Phase 3· Eli Lilly and Company· Source

• Recruiting

  Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

  NCT06234410· University of Edinburgh· Source

• Active, not recruiting

  Study in Patients With Decompensated Liver Cirrhosis

  NCT06380335· Resolution Therapeutics Limited· Source

• Recruiting

  Innate Immunity in COPD

  NCT05743582· University of Edinburgh· Source

• Recruiting

  Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  NCT04124120· Weill Medical College of Cornell University· Source

• Recruiting

  RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure

  NCT05568069· University Hospital Southampton NHS Foundation Trust· Source

• Recruiting

  Return to Golf After Orthopaedic Surgery

  NCT05675618· Hospital for Special Surgery, New York· Source

• Recruiting

  Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial

  NCT05378347· Medtronic Cardiovascular· Source

• Active, not recruiting

  Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

  NCT05570058· Phase 2· Redx Pharma Ltd· Source

• Active, not recruiting

  LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment

  NCT04999423· Microvention-Terumo, Inc.· Source

• Recruiting

  Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

  NCT04936620· St George's, University of London· Source

• Active, not recruiting

  The SELUTION DeNovo Study

  NCT04859985· M.A. Med Alliance S.A.· Source

• Recruiting

  Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

  NCT04774159· Phase 3· Population Health Research Institute· Source

• Recruiting

  RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

  NCT04796350· AgNovos Healthcare, LLC· Source

• Active, not recruiting

  SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

  NCT04722250· Medtronic Cardiovascular· Source

• Recruiting

  A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  NCT04786262· Phase 3· Vertex Pharmaceuticals Incorporated· Source

• Recruiting

  Diurnal BP Patterns in Those at Increased Risk of CVD

  NCT04522765· University of Edinburgh· Source

• Recruiting

  The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

  NCT04204915· University of Leicester· Source

• Active, not recruiting

  Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

  NCT03535298· Phase 4· The Cleveland Clinic· Source

• Recruiting

  Neurovascular Product Surveillance Registry

  NCT02988128· Medtronic Neurovascular Clinical Affairs· Source

• Active, not recruiting

  The British Heart Foundation SENIOR-RITA Trial

  NCT03052036· Newcastle-upon-Tyne Hospitals NHS Trust· Source

• Active, not recruiting

  UK Infinity, Post-Market Clinical Follow-up Study

  NCT03063593· Stryker Trauma and Extremities· Source

• Active, not recruiting

  REDUCER-I: An Observational Study of the Neovasc Reducer™ System

  NCT02710435· Shockwave Medical, Inc.· Source

• Active, not recruiting

  HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

  NCT01915615· University of Virginia· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease6 recruiting
• Heart failure4 recruiting
• Bronchiectasis3 recruiting
• Type 2 diabetes3 recruiting
• Chronic kidney disease2 recruiting
• Depression2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Peripheral artery disease2 recruiting
• Stroke2 recruiting
• Type 1 diabetes2 recruiting
• Aortic aneurysm1 recruiting
• Aortic stenosis1 recruiting
• Atrial fibrillation1 recruiting
• Brain aneurysm1 recruiting
• COPD1 recruiting
• Cystic fibrosis1 recruiting
• Glioblastoma1 recruiting
• Obesity1 recruiting
• Osteoarthritis1 recruiting
• Osteoporosis1 recruiting
• Spinal cord injury1 recruiting

Closed trials

• Completed

  SpinChip Hs-cTnI Clinical Diagnostic Performance

  NCT06499519· SpinChip Diagnostics ASA· Source

• Completed

  Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF

  NCT06331624· Phase 2· GRI Bio Operations, Inc.· Source

• Completed

  Cough Reduction in IPF With Nalbuphine ER

  NCT05964335· Phase 2· Trevi Therapeutics· Source

• Completed

  CT Clock Tool Feasibility Study

  NCT06028802· University of Edinburgh· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

  NCT05660850· Phase 2· Genentech, Inc.· Source

• Completed

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· Phase 3· Bayer· Source

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Boehringer Ingelheim· Source

• Withdrawn

  Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis

  NCT03737617· Phase 4· University of Edinburgh· Source

• Completed

  Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

  NCT05185089· Phase 2· Nerre Therapeutics Ltd.· Source

• Completed

  Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

  NCT04614168· University of Edinburgh· Source

• Completed

  PROFILE-MI - The FAPI Fibrosis Study

  NCT05356923· University of Edinburgh· Source

• Completed

  Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride

  NCT04577716· University of Edinburgh· Source

• Terminated

  IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

  NCT04524949· Phase 2· Imcyse SA· Source

• Completed

  The "MyoThrombus" Study

  NCT04829825· University of Edinburgh· Source

• Completed

  EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

  NCT03950076· Phase 4· Population Health Research Institute· Source

• Completed

  EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

  NCT03594110· Phase 3· Boehringer Ingelheim· Source

• Completed

  CENTERA PMCF: Post-Market Follow-up of the CENTERA Transcatheter Heart Valve System

  NCT03699345· Edwards Lifesciences· Source

• Completed

  PET MRI in Coronary Artery Disease

  NCT03451448· University of Edinburgh· Source

• Completed

  Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

  NCT02699645· Phase 3· The George Institute· Source

• Completed

  A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

  NCT02444338· University Medical Center Goettingen· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Trigeminal neuralgia4 works · 0 trials
• Barrett's oesophagus3 works · 0 trials